Biomarin Pharmaceutical BMRN reported its Q3 earnings results on Wednesday, October 26, 2022 at 04:03 PM.
Here's what investors need to know about the announcement.
Biomarin Pharmaceutical missed estimated earnings by 300.0%, reporting an EPS of $-0.04 versus an estimate of $-0.01.
Revenue was up $96.60 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.48 which was followed by a 5.18% increase in the share price the next day.
Here's a look at Biomarin Pharmaceutical's past performance:
|Quarter||Q2 2022||Q1 2022||Q4 2021||Q3 2021|
To track all earnings releases for Biomarin Pharmaceutical visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.